Multimodality standard of care treatment of resectable and borderline resectable pancreatic cancer

被引：3

作者：

Neoptolemos, John P. ^{[1
]}

Ghaneh, Paula ^{[2
]}

Hackert, Thilo ^{[1
]}

机构：

[1] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany

[2] Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Clin Canc Med, Liverpool, Merseyside, England

来源：

HEPATOBILIARY SURGERY AND NUTRITION | 2021年 / 10卷 / 05期

关键词：

GEMCITABINE; THERAPY;

D O I：

10.21037/hbsn-21-131

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：714 / 716

页数：3

共 7 条

[1] FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Conroy, T.
Hammel, P.
Hebbar, M.
Ben Abdelghani, M.
Wei, A. C.
Raoul, J. -L.
Chone, L.
Francois, E.
Artru, P.
Biagi, J. J.
Lecomte, T.
Assenat, E.
Faroux, R.
Ychou, M.
Volet, J.
Sauvanet, A.
Breysacher, G.
Di Fiore, F.
Cripps, C.
Kavan, P.
Texereau, P.
Bouhier-Leporrier, K.
Khemissa-Akouz, F.
Legoux, J. -L.
Juzyna, B.
Gourgou, S.
O'Callaghan, C. J.
Jouffroy-Zeller, C.
Rat, P.
Malka, D.
Castan, F.
Bachet, J. -B.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (25) : 2395 - 2406
[2] Ghaneh P, 2020, J Clin Oncol., V38, P4505, DOI 10.1200/JCO.2020.38.15_suppl.4505
[3] Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas.
Katz, Matthew H. G.
Shi, Qian
Meyers, Jeffrey P.
Herman, Joseph M.
Choung, Michael
Wolpin, Brian M.
Ahmad, Syed
Marsh, de Wilton Robert
Schwartz, Lawrence Howard
Behr, Spencer
Frankel, Wendy L.
Collisson, Eric Andrew
Leenstra, James Lewis
Williams, Terence Marques
Vaccaro, Gina M.
Venook, Alan P.
Meyerhardt, Jeffrey A.
O'Reilly, Eileen Mary
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
[4] Systemic therapy without radiation may be appropriate as neoadjuvant therapy for localized pancreas cancer
Kizy, Scott
Altman, Ariella M.
Wirth, Keith M.
Marmor, Schelomo
Hui, Jane Y. C.
Tuttle, Todd M.
Lou, Emil
Amin, Khalid
Denbo, Jason W.
Jensen, Eric H.
[J]. HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (03) : 296 - 303
[5] Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
Neoptolemos, John P.
Palmer, Daniel H.
Ghaneh, Paula
Psarelli, Eftychia E.
Valle, Juan W.
Halloran, Christopher M.
Faluyi, Olusola
O'Reilly, Derek A.
Cunningham, David
Wadsley, Jonathan
Darby, Suzanne
Meyer, Tim
Gillmore, Roopinder
Anthoney, Alan
Lind, Pehr
Glimelius, Bengt
Falk, Stephen
Izbicki, Jakob R.
Middleton, Gary William
Cummins, Sebastian
Ross, Paul J.
Wasan, Harpreet
McDonald, Alec
Crosby, Tom
Ma, Yuk Ting
Patel, Kinnari
Sherriff, David
Soomal, Rubin
Borg, David
Sothi, Sharmila
Hammel, Pascal
Hackert, Thilo
Jackson, Richard
Buechler, Markus W.
[J]. LANCET, 2017, 389 (10073) : 1011 - 1024
[6] A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
Neoptolemos, JP
Stocken, DD
Friess, H
Bassi, C
Dunn, JA
Hickey, H
Beger, H
Fernandez-Cruz, L
Dervenis, C
Lacaine, F
Falconi, M
Pederzoli, P
Pap, A
Spooner, D
Kerr, DJ
Büchler, MW
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) : 1200 - 1210
[7] Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma A Phase 2 Randomized Clinical Trial
Sohal, Davendra P. S.
Duong, Mai
Ahmad, Syed A.
Gandhi, Namita S.
Beg, M. Shaalan
Wang-Gillam, Andrea
Wade, James L., III
Chiorean, E. Gabriela
Guthrie, Katherine A.
Lowy, Andrew M.
Philip, Philip A.
Hochster, Howard S.
[J]. JAMA ONCOLOGY, 2021, 7 (03) : 421 - 427

← 1 →